575 (Janumet 500 mg / 50 mg)

Generic Name: metformin/sitagliptin

Pill imprint 575 has been identified as Janumet 500 mg / 50 mg.

Janumet is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Janumet 500 mg / 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 575

Janumet 500 mg / 50 mg 575
Janumet 500 mg / 50 mg 575
Janumet 500 mg / 50 mg 575  Front
Janumet 500 mg / 50 mg 575  Back
Janumet
Generic Name:
metformin/sitagliptin
Imprint:
575
Strength:
500 mg / 50 mg
Color:
Pink
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Merck & Company Inc.
National Drug Code (NDC):
00006-0575
Inactive Ingredients:
ferrosoferric oxide
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k29/32
ferric oxide red
sodium lauryl sulfate
sodium stearyl fumarate
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
35356-0136 Lake Erie Medical and Surgical Supply (repackager)
54868-5973 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)